These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18971831)

  • 61. Pretreatment assessment for the optimal management of early-stage lung cancer.
    Tomaszek SC; Wigle DA
    Cancer J; 2011; 17(1):11-7. PubMed ID: 21263261
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Decision making about operability in non-small cell lung cancer.
    Van Schil P; Hendriks J; De Maeseneer M; Vandenbroeck Ch; Lauwers P
    Acta Chir Belg; 2007; 107(5):495-9. PubMed ID: 18074906
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Standards of surgery in lung cancer].
    Thomas PA
    Rev Prat; 2009 Sep; 59(7):934-8. PubMed ID: 19839459
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chemoradiation for unresectable stage III non-small cell lung cancer.
    Price KA; Azzoli CG; Gaspar LE
    Semin Thorac Cardiovasc Surg; 2008; 20(3):204-9. PubMed ID: 19038729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence.
    Hung JJ; Hsu WH; Hsieh CC; Huang BS; Huang MH; Liu JS; Wu YC
    Thorax; 2009 Mar; 64(3):192-6. PubMed ID: 19252018
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [NSCLC of early stage. The place of surgery].
    Riquet M; Scotte F
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S67-71. PubMed ID: 18971828
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy.
    Forquer JA; Fakiris AJ; McGarry RC; Cheung MK; Watson C; Harkenrider M; Henderson MA; Lo SS
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1443-53. PubMed ID: 19828006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is pneumonectomy justified in patients with locally advanced NSCLC and persistent N2 disease after induction chemotherapy?
    Klomp HM; Kappers I
    Ann Thorac Surg; 2009 Mar; 87(3):990-1. PubMed ID: 19231456
    [No Abstract]   [Full Text] [Related]  

  • 69. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 70. How much skill should we need for a VATS lobectomy in stage I lung cancer? An evaluation of surgeon groups.
    Iwasaki A; Yamamoto S; Shiraishi T; Shirakusa T
    Int Surg; 2008; 93(3):169-74. PubMed ID: 18828273
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Early-stage NSCLC. The renaissance of radiotherapy in early-stage non-small cell lung cancer].
    Girard N; Mornex F
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S79-87. PubMed ID: 18971830
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Surgery for Stage III Non-Small Cell Lung Cancer.
    Rusch VW
    Cancer Control; 1994 Oct; 1(5):455-466. PubMed ID: 10887000
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Surgery for small-cell lung cancer.
    Anraku M; Waddell TK
    Semin Thorac Cardiovasc Surg; 2006; 18(3):211-6. PubMed ID: 17185181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Morbidity in video-assisted thoracoscopic lobectomy for clinical stage I non-small cell lung cancer: is VATS lobectomy really safe?
    Kawachi R; Tsukada H; Nakazato Y; Takei H; Koshi-ishi Y; Goya T
    Thorac Cardiovasc Surg; 2009 Apr; 57(3):156-9. PubMed ID: 19330753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prognosis of stage pIIIA non small cell lung cancer after mediastinal lymph node dissection or sampling.
    Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
    J BUON; 2009; 14(1):45-9. PubMed ID: 19373946
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lung cancer surgery in the elderly.
    Gonzalez-Aragoneses F; Moreno-Mata N; Simon-Adiego C; Peñalver-Pascual R; Gonzalez-Casaurran G; Perea LA
    Crit Rev Oncol Hematol; 2009 Sep; 71(3):266-71. PubMed ID: 18996718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The surgical management of lung cancer.
    Posther KE; Harpole DH
    Cancer Invest; 2006 Feb; 24(1):56-67. PubMed ID: 16466994
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do bone marrow isolated tumor cells influence long-term survival of non-small cell lung cancer?
    Ruffato A; Mattioli S; Pileri S; Daddi N; D'Ovidio F; Pilotti V; Tazzari P
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):463-8. PubMed ID: 19150243
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Clinical significance of pleural lavage cytology for non-small cell lung cancer: is surgical resection valid for patients with positive pleural lavage cytology?
    Kawachi R; Nakazato Y; Masui K; Takei H; Koshi-ishi Y; Goya T
    Interact Cardiovasc Thorac Surg; 2009 Aug; 9(2):265-8. PubMed ID: 19429636
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease: a review article.
    Toyokawa G; Takenoyama M; Ichinose Y
    Clin Lung Cancer; 2015 Jan; 16(1):6-14. PubMed ID: 25220209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.